Androgen/NN
binding/NN
sites/NNS
in/IN
peripheral/JJ
human/JJ
mononuclear/JJ
leukocytes/NNS
of/IN
healthy/JJ
males/NNS
and/CC
females/NNS
./.

Androgen/NN
binding/NN
sites/NNS
have/VBP
been/VBN
identified/VBN
in/IN
circulating/VBG
human/JJ
mononuclear/JJ
leukocytes/NNS
of/IN
healthy/JJ
donors/NNS
of/IN
both/DT
sexes/NNS
./.
=====
Cells/NNS
were/VBD
separated/VBN
from/IN
blood/NN
samples/NNS
on/IN
a/DT
Ficoll/NN
gradient/NN
and/CC
incubated/VBN
with/IN
different/JJ
concentrations/NNS
of/IN
[3H]testosterone/NN
in/IN
the/DT
presence/NN
or/CC
absence/NN
of/IN
a/DT
400-fold/JJ
excess/NN
of/IN
unlabelled/JJ
testosterone/NN
./.
=====
Binding/NN
data/NNS
were/VBD
derived/VBN
from/IN
Scatchard/NN
analysis/NN
./.
=====
The/DT
binding/VBG
sites/NNS
fulfil/VBP
the/DT
required/JJ
criteria/NNS
for/IN
specific/JJ
steroid/NN
binding/NN
sites/NNS
however/RB
differ/VBP
somewhat/RB
from/IN
the/DT
classic/JJ
androgen/NN
receptors/NNS
from/IN
genital/JJ
skin/NN
fibroblast/NN
:/:
in/IN
fertile/JJ
adult/JJ
males/NNS
(/(
n/NN
=/JJ
20/CD
)/)
the/DT
binding/VBG
sites/NNS
showed/VBD
(/(
1/LS
)/)
a/DT
high/JJ
affinity/NN
for/IN
testosterone/NN
(/(
1.32/CD
+/-/JJ
0.49/CD
nM/NN
;/:
mean/NN
+/-/JJ
SD/NN
)/)
,/,
(/(
2/LS
)/)
a/DT
saturable/JJ
capacity/NN
(/(
184/CD
+/-/JJ
52/CD
binding/VBG
sites/NNS
per/IN
cell/NN
;/:
mean/NN
+/-/JJ
SD/NN
)/)
,/,
and/CC
(/(
3/LS
)/)
a/DT
characteristic/JJ
competitive/JJ
binding/NN
profile/NN
for/IN
other/JJ
steroid/NN
hormones/NNS
(/(
relative/JJ
binding/NN
affinities/NNS
:/:
testosterone/NN
=/JJ
dihydrotestosterone/NN
>/JJR
17/CD
beta-estradiol/NN
>/JJR
progesterone/NN
,/,
whereas/IN
aldosterone/NN
,/,
17-hydroxy-progesterone/NN
and/CC
cortisol/NN
did/VBD
not/RB
compete/VB
appreciably/RB
)/)
./.
=====
Furthermore/RB
the/DT
number/NN
of/IN
binding/VBG
sites/NNS
determined/VBN
using/VBG
[3H]dihydrotestosterone/NN
,/,
[3H]RU-1881/NN
,/,
or/CC
[3H]testosterone/NN
were/VBD
comparable/JJ
./.
=====
This/DT
raises/VBZ
the/DT
possibility/NN
that/IN
androgen/NN
receptors/NNS
in/IN
peripheral/JJ
mononuclear/JJ
leukocytes/NNS
differ/VBP
from/IN
those/DT
in/IN
genital/JJ
skin/NN
fibroblasts/NNS
./.
=====
There/EX
was/VBD
no/DT
apparent/JJ
correlation/NN
between/IN
serum/NN
testosterone/NN
concentrations/NNS
and/CC
androgen/NN
binding/NN
sites/NNS
./.
=====
In/IN
fertile/JJ
women/NNS
remarkable/JJ
changes/NNS
in/IN
androgen/NN
binding/NN
sites/NNS
were/VBD
seen/VBN
in/IN
the/DT
course/NN
of/IN
the/DT
menstrual/JJ
cycle/NN
,/,
with/IN
a/DT
significant/JJ
increase/NN
in/IN
the/DT
immediate/JJ
preovulatory/JJ
period/NN
./.
=====
The/DT
presence/NN
of/IN
androgen/NN
receptors/NNS
in/IN
peripheral/JJ
mononuclear/JJ
leukocytes/NNS
provides/VBZ
for/IN
the/DT
first/JJ
time/NN
the/DT
experimental/JJ
basis/NN
for/IN
an/DT
hypothesis/NN
of/IN
direct/JJ
,/,
receptor-mediated/JJ
effects/NNS
of/IN
androgens/NNS
on/IN
mature/JJ
immunocompetent/JJ
cells/NNS
./.
=====
The/DT
immunological/JJ
implications/NNS
of/IN
these/DT
results/NNS
are/VBP
discussed/VBN
./.